Results 201 to 210 of about 2,022,996 (246)

Resistance to PD-1/PD-L1 blockade: Mechanism and pharmacological strategies. [PDF]

Pharmacol Res
Kim AMJ, Lee N, Chen HY, Lim SO.
europepmc   +1 more source

Dynamic peripheral immune monitoring during checkpoint blockade: a framework for interpreting response, toxicity and resistance. [PDF]

Front Immunol
Gao L, Jin Y.
europepmc   +1 more source

DEA hypothesis: disinhibition, enhancing recognition, and alerting the host are the three pillars of effective cancer immunotherapy. [PDF]

J Immunother Cancer
Wang XS, Lotze MT.
europepmc   +1 more source

Distinct spatial immune architectures in tumor and tumor-adjacent tissues of early-stage non-small cell lung cancer. [PDF]

Front Immunol
Polic I, Arrechedera C, Slone JK, Montoya A, Bontekoe E, Jiang P, Patel A, Karpinets TV, Wu X, Song X, Luo Q, Ibarguen H, Tamegnon A, Jiang M, Haymaker C, Weissferdt A, Vaporciyan AA, Kavraki LE, Cascone T, Wistuba I, Solis Soto LM, Heymach JV, Zhang J, Gibbons DL, Reuben A.   +24 more
europepmc   +1 more source

Intratumoral heterogeneity as a potential biomarker for immunotherapy response and postoperative recurrence in NSCLC. [PDF]

Front Immunol
Wang Y, Dong X, Yin Y, Lin Z, Ren P, Zheng Y, Wang H.   +6 more
europepmc   +1 more source

Cancer Vaccines in Genitourinary Malignancies: Current Advances and Future Directions. [PDF]

Vaccines (Basel)
Altay H, Al-Hashimi I, Matthews J, DeAlessandro G, Ghelani GH.   +4 more
europepmc   +1 more source

Colorectal cancer and tumor vaccines (Review). [PDF]

Oncol Lett
Ma J, Xiang C, Xia D.
europepmc   +1 more source

Inverse relationship between neoantigen clonality and T-cell activity reveals distinct immune phenotypes in HNSCC. [PDF]

J Transl Med
Saravi B, Singh DD, Schorn L, Lommen J, Schrader F, Wilkat M, Vollmer A, Vollmer M, Hartmann S, Hörner M, Adhikari K, Roider E, Wollborn J, Kübler N, Sproll C.   +14 more
europepmc   +1 more source

Targeting splicing-derived neoantigens for precision cancer immunotherapy. [PDF]

Front Immunol
Tang M, Grimes HL, Salomonis N.
europepmc   +1 more source